𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Parenteral antischistosomal therapy: A potential risk factor for hepatitis B infection

✍ Scribed by Kenneth C. Hyams; Moustafa M. Mansour; Ahmed Massoud; Michael A. Dunn

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
374 KB
Volume
23
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

To study the association between hepatitis B and schistosomiasis, 1,234 Egyptian males, ages 18 to 24, were interviewed, examined, and tested for Schistosoma mansoni infection and HBsAg. Sera from 91 (7.4%) of the study subjects were positive for HBsAg, and S. mansoni was found in the stools of 26.3%. There was no correlation between S. mansoni infection, with or without hepatosplenomegaly, or a history of schistosomiasis, and HBsAg. An association was found between HBsAg positivity and a previous history of parenteral antischistosomal therapy (P less than 0.01). The results of the study indicate that parenteral therapy for schistosomiasis may be a risk factor for hepatitis B antigenemia. Further studies are indicated to determine the importance of parenteral therapy in the transmission of hepatitis B.

πŸ“œ SIMILAR VOLUMES

A case–control study of risk factors for
A case–control study of risk factors for hepatitis B virus infection in North Jordan
✍ Wail A. Hayajneh; Hani A. Masaadeh; Yaseen A. Hayajneh πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 58 KB πŸ‘ 1 views

## Abstract Jordan is a country with intermediate endemicity for hepatitis B virus (HBV) infection where risk factors for viral transmission and their relative contributions are not well known. A case–control study of 100 hepatitis B virus seropositive patients and another 100 seronegative controls

Hepatitis C virus infection as a risk fa
Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in taiwan
✍ Jung-Fa Tsai; Wen-Yu Chang; Jen-Eing Jeng; Mei-Shang Ho; Liang-Yen Wang; Ming-Yu πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 470 KB πŸ‘ 2 views

## Abstract To assess whether hepatitis C virus infection was a risk factor for the development of non‐alcoholic liver cirrhosis, antibody to hepatitis C virus (anti‐HCV; detected by a second generation HCV enzyme immunoassay), hepatitis B surface antigen (HBsAg; detected by radioimmunoassay) were

Hepatic steatosis is a risk factor for h
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
✍ Kazuyuki Ohata; Keisuke Hamasaki; Kan Toriyama; Kojiro Matsumoto; Akira Saeki; K πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 3 views

## Abstract ## BACKGROUND Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of

Occult HBV infection may represent a maj
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C
✍ S. Mrani; I. Chemin; K. Menouar; O. Guillaud; P. Pradat; G. Borghi; M.A. Trabaud πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract Occult hepatitis B virus (HBV) infection is common in chronic hepatitis C patient. However, its significance and consequences are still unclear. The aim of this study was to evaluate the prevalence of occult HBV among HCV chronic carriers in France and to assess its impact on liver hist